RBC Capital Names Top 30 Global Stock Ideas for 2026
RBC Capital updated its Top 30 Global Ideas list for 2026, adding Apotex Health, Canadian National Railway (CNR), and Lonza (LONN). The list delivered an 11.1% return in Q2/26. CNR reported Q2/26 earnings of C$2.08 per share on $4.75B revenue, raising its full-year guidance. RBC highlights CNR's discount valuation, Apotex's market share, and Lonza's growth potential.
How this was made
The 30-second read
Why it matters
The inclusion highlights CNR as a high-conviction pick, reinforcing the earnings beat significance.
Market read
CNR's earnings beat and guidance raise are likely to influence transportation sector sentiment and RBC's stock idea list.
What to watch
Potential regulatory or fuel cost pressures could offset earnings gains.
Background
RBC Capital updated its Top 30 Global Stock Ideas for 2026, adding Canadian National Railway among three new picks.
Ticker impact
Canadian National Railway reported Q2 2026 adjusted earnings of C$2.08 per share, beating estimates and raising full-year guidance.
Potential upside of 5-8% in the near term as investors price in higher earnings.
The beat was unexpected and guidance was raised, indicating improved operating leverage.
Market effects
Rail and broader industrial logistics may benefit from higher freight volumes.
Positive for North American transportation sector.
Adds to optimism for global supply-chain recovery.
Counterpoint
If freight rates plateau, the guidance raise may be premature.
Key entities
- companyCanadian National Railway
Railroad operator listed on NYSE (CNR).

